Results 301 to 310 of about 166,832 (321)

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

Journal of the American College of Cardiology, 2014
Saibal Kar, Matthew J Price, Brian K Whisenant   +2 more
exaly  

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

Circulation, 2015
David J Graham, Marsha E Reichman, Ting-Chang Sheu   +2 more
exaly  

Warfarin

Reactions Weekly, 2017
  +4 more sources

Warfarin

Reactions Weekly, 2013
openaire   +1 more source

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

Circulation, 2013
Stuart J Connolly, Jonas Oldgren, John W. Eikelboom   +2 more
exaly  

Warfarin

Reactions Weekly, 2015
openaire   +2 more sources

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

Lancet, The, 2016
Andreas Goette, JosÉ Luis Merino, Joris R De Groot   +2 more
exaly  

Warfarin

Reactions Weekly, 2009
openaire   +1 more source

Warfarin

Reactions Weekly, 2002
openaire   +1 more source

Warfarin

Reactions Weekly, 2018
openaire   +2 more sources